Correction: Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials

There are errors in the Funding section. The correct Funding statement is: This research was supported by the National Evidence-based Collaborating Agency, Republic of Korea (grant number: NA22-008 and NA23-010). There was no additional internal or external funding received for this study. The funding source had no role in the study design, data collection, and analysis, decision to publish, or manuscript preparation of the manuscript.